May 11, 2021
Walmart Inc. has asked the Fifth Circuit to resurrect its lawsuit against the U.S. Department of Justice in which the retail giant sought a declaration that its prescription opioid sales are lawful, arguing that pre-enforcement review is a standard route for entities looking to clarify the scope of the law without waiting to be sued.
March 04, 2021
Business groups, a pro-business think tank and a drug store advocacy group have backed Walmart's attempt to torpedo the federal government's suit claiming the retail chain helped spur the nationwide opioid epidemic by failing to scrutinize suspicious prescriptions.
February 22, 2021
The U.S. Department of Justice's allegations that Walmart helped spur the nationwide opioid epidemic by failing to scrutinize suspicious prescriptions are "sensationalist" and should be tossed, the retail chain told a Delaware federal judge on Monday, saying pharmacists don't have the training to second-guess doctors' medical judgments.
January 06, 2021
Walmart Inc. on Wednesday unleashed fresh allegations of dodgy behavior by U.S. Department of Justice attorneys investigating its sales of prescription opioids, accusing government lawyers of making "disingenuous" statements in Texas federal court about looming enforcement.
December 22, 2020
A bare-knuckle lawsuit from the U.S. Department of Justice portrays Walmart Inc. as a major driver of the opioid crisis. Here, Law360 examines five key highlights from Tuesday's complaint, which seeks penalties that could reach into the billions of dollars.
December 22, 2020
The U.S. Department of Justice hit Walmart with a suit Tuesday in Delaware federal court alleging the retail chain helped spur the nationwide opioid epidemic by failing to scrutinize suspicious prescriptions and making it hard for its pharmacists to comply with rules for controlled substances.